Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05722977
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-10
First Post:
2023-02-01
Brief Title:
Surufatinib and Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-02-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-02
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-01
First Submit QC Date:
February 1 2023
Study First Post Date:
2023-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-01
Last Update Post Date:
2023-02-10
Last Update Post Date Type:
ACTUAL